SI
SLXP

Scout Investments’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

Scout Investments’s Portfolio SLXP Stock Details SLXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-15,594
Closed -$2.69M – 313
2015
Q1 		$2.69M Sell
15,594
-219,577
-93% -$32.2M 0.04% 213
2014
Q4 		$27M Buy
235,171
+183,372
+354% +$22.2M 0.41% 87
2014
Q3 		$8.09M Sell
51,799
-26,848
-34% -$3.89M 0.11% 122
2014
Q2 		$9.7M Sell
78,647
-15,167
-16% -$1.68M 0.11% 118
2014
Q1 		$9.72M Sell
93,814
-7,607
-8% -$779K 0.11% 124
2013
Q4 		$9.12M Sell
101,421
-3,625
-3% -$289K 0.1% 132
2013
Q3 		$7.03M Sell
105,046
-3,750
-3% -$258K 0.05% 193
2013
Q2 		$7.2M Buy
+108,796
New +$6.22M 0.08% 140

Other funds holding SLXP

MMG
Monetary Management Group St Louis, Missouri $419M AUM 29.55% 1-Year Est. Return

Scout Investments's SLXP Position: Q2 2015 in Review

Scout Investments sold out of SALIX PHARMACEUTICALS LTD DEL (SLXP) in Q2 2015, closing a stake of 15,594 shares — an estimated $2.69M sold.

Scout Investments first reported a position in SLXP in Q2 2013 and held it in 8 quarters. The position peaked at $27M in Q4 2014. 1 fund tracked by Wall St. Rank holds SLXP as of Q2 2015.

  • Scout Investments reported no remaining SALIX PHARMACEUTICALS LTD DEL position as of Q2 2015 after selling out during the quarter.
  • Scout Investments sold 15,594 SALIX PHARMACEUTICALS LTD DEL shares in Q2 2015, an estimated $2.69M.
  • Scout Investments first reported a position in SALIX PHARMACEUTICALS LTD DEL in Q2 2013 and held it in 8 quarters.
  • Scout Investments's SALIX PHARMACEUTICALS LTD DEL position peaked at $27M in Q4 2014.
  • 1 fund tracked by Wall St. Rank held SALIX PHARMACEUTICALS LTD DEL as of Q2 2015.

Based on Scout Investments's 13F filing for Q2 2015, filed 3 Aug 2015.